Especially in the initial phase of a project, start-ups and biotechs need support in making strategic decisions that often determine the success or failure of a project. Many companies offer services of varying quality in the drug development process. I accompany companies, help to classify the necessary development components, and arrange contacts to high quality service providers.
Due diligence as critical assessment of novel assets in drug research and corresponding translational strategies supports investors such as VC Funds with identification of valuable projects and risk minimization. Asking the right questions in the beginning of a project can generate added value in the long run.